0001209191-23-021743.txt : 20230330
0001209191-23-021743.hdr.sgml : 20230330
20230330210435
ACCESSION NUMBER: 0001209191-23-021743
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230328
FILED AS OF DATE: 20230330
DATE AS OF CHANGE: 20230330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mancini Marianna
CENTRAL INDEX KEY: 0001838112
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37355
FILM NUMBER: 23782665
MAIL ADDRESS:
STREET 1: C/O VIKING THERAPEUTICS, INC.
STREET 2: 12340 EL CAMINO REAL, STE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viking Therapeutics, Inc.
CENTRAL INDEX KEY: 0001607678
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461073877
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-704-4660
MAIL ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-28
0
0001607678
Viking Therapeutics, Inc.
VKTX
0001838112
Mancini Marianna
C/O VIKING THERAPEUTICS, INC.
9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO
CA
92121
0
1
0
0
Chief Operating Officer
0
Common Stock, par value $0.00001 per share
2023-03-28
4
M
0
15000
2.15
A
332273
D
Common Stock, par value $0.00001 per share
2023-03-28
4
M
0
4873
1.88
A
337146
D
Common Stock, par value $0.00001 per share
2023-03-28
4
M
0
15000
1.26
A
352146
D
Common Stock, par value $0.00001 per share
2023-03-28
4
M
0
53054
1.23
A
405200
D
Common Stock, par value $0.00001 per share
2023-03-28
4
M
0
15000
1.08
A
420200
D
Common Stock, par value $0.00001 per share
2023-03-28
4
M
0
10000
1.04
A
430200
D
Common Stock, par value $0.00001 per share
2023-03-28
4
M
0
24500
4.65
A
454700
D
Common Stock, par value $0.00001 per share
2023-03-28
4
M
0
30000
4.37
A
484700
D
Common Stock, par value $0.00001 per share
2023-03-28
4
S
0
196563
15.00
D
288137
D
Common Stock, par value $0.00001 per share
2023-03-29
4
M
0
15000
9.13
A
303137
D
Common Stock, par value $0.00001 per share
2023-03-29
4
S
0
41242
16.00
D
261895
D
Stock Option (right to buy)
2.15
2023-03-28
4
M
0
15000
0.00
D
2017-03-04
2026-03-04
Common Stock
15000
0
D
Stock Option (right to buy)
1.88
2023-03-28
4
M
0
4873
0.00
D
2016-03-14
2026-03-14
Common Stock
4873
0
D
Stock Option (right to buy)
1.26
2023-03-28
4
M
0
15000
0.00
D
2017-06-30
2026-06-30
Common Stock
15000
0
D
Stock Option (right to buy)
1.23
2023-03-28
4
M
0
53054
0.00
D
2017-01-05
2027-01-05
Common Stock
53054
0
D
Stock Option (right to buy)
1.08
2023-03-28
4
M
0
15000
0.00
D
2018-06-30
2027-06-30
Common Stock
15000
0
D
Stock Option (right to buy)
1.04
2023-03-28
4
M
0
10000
0.00
D
2018-08-31
2027-08-31
Common Stock
10000
0
D
Stock Option (right to buy)
4.65
2023-03-28
4
M
0
24500
0.00
D
2019-01-19
2028-01-19
Common Stock
24500
0
D
Stock Option (right to buy)
4.37
2023-03-28
4
M
0
30000
0.00
D
2019-03-30
2028-03-30
Common Stock
30000
0
D
Stock Option (right to buy)
9.13
2023-03-29
4
M
0
15000
0.00
D
2016-05-21
2025-05-21
Common Stock
15000
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person.
25% of the shares subject to the option vested on each one year anniversary of the grant date.
The shares subject to the option vested on the grant date.
23,054 shares vested on the grant date of 01/05/2017 and 25% of the remaining 30,000 shares subject to the option vested on each one year anniversary of the grant date.
One-third of the shares subject to the option vested on each one year anniversary of the grant date.
/s/ Michael Morneau as Attorney-in-Fact
2023-03-30